PROCAL INJ

PROCAL INJ. is a Kepro veterinary product developed to provide a clearly defined therapeutic or nutritional role. Its formulation is based on calcium gluconate 350 mg/ml and calcium glucoheptonate 100 mg/ml. These components give the product a practical place in veterinary programs aimed at support in hypocalcaemic conditions including milk fever and postpartum paresis, and prevention or treatment of calcium deficiency in indicated species. The dosage form is designed for professional animal use and should be incorporated into a treatment or support plan only in accordance with the approved label and local registration.
From a functional perspective, The two soluble calcium sources provide parenteral calcium that can be absorbed rapidly, helping restore circulating calcium when physiological demand exceeds intake or mobilization. This profile explains why the product may be useful when a veterinarian wants to address a specific physiological or clinical need rather than treat signs without identifying their cause. According to available product information, target species include cattle, horses, calves, foals, sheep, goats, pigs, piglets, dogs, cats and rabbits. Final case selection still depends on diagnosis, age, body weight, production stage and the presence of concurrent disease or medicines that could influence response or safety.
A key strength of PROCAL INJ. is the combination of a recognizable active profile with a veterinary dosage form suited to routine clinic or farm use. When selected for the right case, it can form part of a broader program intended to support or treat support in hypocalcaemic conditions including milk fever and postpartum paresis, and prevention or treatment of calcium deficiency in indicated species. It should not be presented as a universal answer to every animal showing the same clinical sign, because similar signs may arise from very different infectious, nutritional, metabolic or management-related causes.
Calcium disorders deserve prompt assessment because they may affect muscle, cardiac and neurologic function and often occur around parturition or high milk production. Injectable calcium should be administered carefully and animals should be monitored, especially during intravenous use, because overly rapid increases in circulating calcium can trigger adverse cardiac effects. Long-term prevention also depends on ration design, mineral balance and appropriate vitamin D status.
This copy is written for a veterinary product page, so it focuses on product identity, clinical or nutritional role, and practical positioning rather than reproducing a dosing leaflet. The product should always be used according to the locally approved label and package leaflet because authorized species, dosage schedules, withdrawal periods, contraindications and warnings may differ between markets. Appropriate veterinary use also depends on diagnosis, body weight, age, kidney and liver status, pregnancy or lactation, concurrent medicines and, for antimicrobials, the likely or confirmed susceptibility of the causative organism. Website information should therefore complement, not replace, professional veterinary advice and the manufacturer’s approved instructions.
For a website product page, PROCAL INJ. can be positioned as a specialized Kepro option with a defined formulation and a clear practical purpose. A complete page should ideally show the original pack, dosage form, principal active ingredients, registered target species and the general therapeutic or nutritional role. Detailed dosage, withdrawal and contraindication information should remain linked to the official leaflet or be provided by a veterinarian. This approach gives customers useful, professional information while keeping regulatory and clinical decisions where they belong: with the approved product information and qualified veterinary guidance.